Clinical Trial Update: Efficacy of Dihydroartemisinin for Treating Female Androgenetic Alopecia [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 clinical trial is evaluating dihydroartemisinin for female androgenetic alopecia, and the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Androgenetic Alopecia

Drugs mentioned

• Dihydroartemisinin (dihydroartemisinin)

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Androgenetic Alopecia (AGA) | EARLY_Phase 1 | Status: RECRUITING